Literature DB >> 2849299

The expression of the platelet-derived and transforming growth factor genes in human nonsmall lung cancer cell lines is related to tumor stroma formation in nude mice tumors.

J Bergh1.   

Abstract

Human lung cancer could be separated into two major groups, small cell lung cancer (SCLC), or non-SCLC based on morphology, biochemical profile, and clinical management. The SCLC group is characterized by a wide spectrum of neuroendocrine markers, while the non-SCLC group is defined by epithelial markers. The non-SCLC cell lines studied have also been demonstrated to express elevated mRNA levels for platelet-derived growth factors and transforming growth factors, while SCLC cell lines were negative for these genes. Four human SCLC cell lines and six human non-SCLC cell lines were inoculated into seventeen nude mice. All studied tumors from the non-SCLC cell lines demonstrated prominent fibrous stromata, although with variability between the individual cell lines. The SCLC cell lines were deprived of significant stroma reaction. These findings may be of importance in explaining the biologic and clinical differences between non-SCLC and SCLC.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849299      PMCID: PMC1880798     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

1.  Characterization of the receptor for platelet-derived growth factor on human fibroblasts. Demonstration of an intimate relationship with a 185,000-Dalton substrate for the platelet-derived growth factor-stimulated kinase.

Authors:  C H Heldin; B Ek; L Rönnstrand
Journal:  J Biol Chem       Date:  1983-08-25       Impact factor: 5.157

2.  Establishment and identification of small cell lung cancer cell lines having classic and variant features.

Authors:  D N Carney; A F Gazdar; G Bepler; J G Guccion; P J Marangos; T W Moody; M H Zweig; J D Minna
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

3.  Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.

Authors:  A F Gazdar; D N Carney; M M Nau; J D Minna
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

4.  Expression of epidermal and nerve growth factor receptors and soft agar growth factor production by human lung cancer cells.

Authors:  S A Sherwin; J D Minna; A F Gazdar; G J Todaro
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

5.  Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small-cell human lung carcinoma lines.

Authors:  G Söderdahl; C Betsholtz; A Johansson; K Nilsson; J Bergh
Journal:  Int J Cancer       Date:  1988-04-15       Impact factor: 7.396

6.  Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.

Authors:  F Cuttitta; D N Carney; J Mulshine; T W Moody; J Fedorko; A Fischler; J D Minna
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

7.  Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung.

Authors:  J Bergh; K Nilsson; R Ekman; B Giovanella
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1985-05

Review 8.  The biochemistry and physiology of the receptor-kinase for epidermal growth factor.

Authors:  G Carpenter
Journal:  Mol Cell Endocrinol       Date:  1983-07       Impact factor: 4.102

9.  Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation.

Authors:  J Bergh; K Nilsson; D Dahl; L Andersson; I Virtanen; V P Lehto
Journal:  Lab Invest       Date:  1984-09       Impact factor: 5.662

10.  Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma).

Authors:  H Baillie-Johnson; P R Twentyman; N E Fox; G A Walls; P Workman; J V Watson; N Johnson; J G Reeve; N M Bleehen
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

View more
  10 in total

1.  A novel transforming growth factor beta2 antisense transcript in mammalian lung.

Authors:  R K Coker; G J Laurent; K Dabbagh; J Dawson; R J McAnulty
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

2.  Serum response heterogeneity among nonsmall cell lung cancer cell lines.

Authors:  K T Goldsmith; C M Listinsky; R I Garver
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

Review 3.  Growth factors and oncogenes in human gastrointestinal carcinomas.

Authors:  E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

4.  v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line.

Authors:  J P Falco; S B Baylin; R Lupu; M Borges; B D Nelkin; R K Jasti; N E Davidson; M Mabry
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

5.  Transforming growth factor-beta 1 (TGF-beta 1)- and beta 2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer.

Authors:  J Maeda; N Ueki; T Ohkawa; N Iwahashi; T Nakano; T Hada; K Higashino
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

6.  Expression of transforming growth factor-alpha in primary human colon and lung carcinomas.

Authors:  C Liu; A Woo; M S Tsao
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

7.  Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane.

Authors:  E Y Yang; H L Moses
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

8.  Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines.

Authors:  L Damstrup; K Rygaard; M Spang-Thomsen; H Skovgaard Poulsen
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

9.  Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines.

Authors:  N E Heldin; K Usuki; J Bergh; B Westermark; C H Heldin
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

10.  Coexpression of platelet-derived growth factor (PDGF) A-chain and PDGF receptor genes in human gastric carcinomas.

Authors:  T Tsuda; K Yoshida; T Tsujino; H Nakayama; G Kajiyama; E Tahara
Journal:  Jpn J Cancer Res       Date:  1989-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.